Maze Therapeutics growth metrics data for the quarter ended Jun 2026. These growth metrics cover 6 quarters of results from Sep 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Sep2024 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|
| Growth Ratios | ||||||
| EBITDA Margin (QoQ) | -105374.00 | |||||
| EBIT Margin (QoQ) | -105374.00 | |||||
| EBT Margin (QoQ) | -108656.00 | |||||
| FCF Margin (QoQ) | -102013.00 | |||||
| Interest Coverage Ratio (QoQ)Interest Cover (QoQ) | -68.27% | |||||
| Net Margin (QoQ) | -107352.00 | |||||
| Operating Margin (QoQ) | -105374.00 | |||||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | -3788.00 | 1,882.00 | ||||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | -5574.00 | 358.00 | 1,225.00 | 203.00 | 97.00 | |
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | -5335.00 | 1,002.00 | ||||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | -6091.00 | 269.00 | 258.00 | 230.00 | 246.00 | |
| Return on Sales [ROS] Growth (1y)ROS Growth (1y) | -511778.00 | -16273.00 | 430,514.00 | |||
| Return on Sales [ROS] (QoQ)ROS (QoQ) | -105374.00 | -506317.00 | -59529.00 |